Pulse Today

Targeted COPD testing proposed as pilot study finds half of high-risk patients affected

Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.
The Hearty Soul on MSN

8 Health Red Flags Every Man in Midlife Should Watch Out For

Midlife hits fast, and your body gets more opinionated about everything with age. However, that is not a crisis; it is a cue ...
Labmate Online

New app enables remote monitoring of chronic respiratory disease

Rx, a digital medicine company specialising in pulmonary care, has announced the launch of pDx, a mobile and web-accessible ...
Healio

Pooled analysis reveals lower risk for severe exacerbations with dupilumab in COPD

Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
Healio

Biologics lower rate of admissions requiring noninvasive ventilation in COPD

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

AstraZeneca furthers ambition to redefine cancer care with first data from four major pivotal trials at ESMO

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...